The evolving role of lateral lumbar interbody fusion in lumbar fusion: challenging the dominance of transforaminal interbody fusion
Introduction
Lumbar spinal fusion depends on robust interbody fusion of the anterior column. Historically, this has been achieved via a posterior approach, mandating an adequate direct neural decompression to place the interbody cages. Surgeons now have a range of approaches to the anterior column—anterior, anterolateral, lateral, posterolateral, and posterior—each with various advantages and disadvantages (1). Data from the Millennium Research Group showed that the transforaminal interbody fusion (TLIF) approach accounted for over 50% of the spinal fusion surgery market in the USA in 2019, with lateral lumbar interbody fusion (LLIF) accounting for 25%. Posterior lumbar interbody fusion (PLIF) and anterior lumbar interbody fusion (ALIF) accounted for only 15% and 10%, respectively. These figures are not dissimilar to Australian spine surgeon practices. From a growth perspective, it is projected that whilst TLIF will continue to grow at 3.6% per annum, PLIF and ALIF procedures will drop by 6.7% and 3.6% annually. However, LLIF will likely grow at 10.2%, nearly equalling TLIF by 2030 as the most common spinal interbody fusion approach (2).
Changes in fusion techniques and approaches
TLIF has recently come under scrutiny due to the push towards more complete discectomies and the placement of larger interbody cages into the anterior column (Figure 1), thereby affording more stability and improved segmental lordosis. From a biomechanical standpoint, placement of a narrow footprint interbody cage across the cancellous bony endplates creates pivoting forces and point loading, increasing rates of subsidence and lowering fusion rates, especially in the absence of bone morphogenetic protein [recombinant human bone morphogenetic protein-2 (rhBMP-2)] authorisation in Australia (3). Minimally invasive (MIS)-TLIF, while preserving the contralateral facet joint and posterior spino-ligamentous structures, limits posterior compression and thus lordosis. Bilateral approaches with posterior column osteotomies are often needed to maximise lordosis. Recent technologies such as endoscopic-assisted TLIFs and biplanar expandable cages aim to improve disc clearance, endplate preparation, and segmental lordosis (4). Nevertheless, TLIF remains the workhorse of lumbar interbody fusion (LIF) approaches and will continue to grow steadily. PLIF demands bilateral retraction of neural structures to access the disc space. While widely taught, it is physically demanding and increases patient morbidity through risks such as durotomy, motor deficits, and epidural fibrosis. Combined with extensive paraspinal muscle dissection, PLIF has fallen out of favour, declining by 6.7% per year. ALIF allows the placement of a wide-footprint cage with high fusion rates at the lumbosacral junction, making it attractive for deformity cases (5). Lateral ALIF innovations permit L5/S1 and higher levels to be accessed in a single position (6,7). However, the need for an access surgeon, and risks such as vascular injury and retrograde ejaculation, have hindered uptake. ALIF procedures are projected to halve by 2030.
Advances and adoption of LLIF
Initially, uptake of LLIF was low due to unfamiliarity with the retroperitoneal approach and risks to the lumbar plexus. Reports of transient sensory deficits (0–75%) and motor deficits (up to 36%) discouraged surgeons (8). Nevertheless, LLIF allows excellent disc clearance, endplate preparation, and placement of large cages spanning the apophyseal ring (Figure 2), achieving good clinical outcomes (9,10). Interfixated LLIF has also been effective for adjacent segment disease (11,12). The shift towards accessing the spine via an oblique lateral interbody fusion (OLIF) anterior to psoas (ATP) corridor purportedly decreased risks to the lumbar plexus (13). Although OLIF provided L5/S1 access, it introduced higher vascular risks and remained prone to nerve injuries (14). Neuromonitoring evolved from basic triggered electromyography (EMG) to a multimodal approach combining EMG and somatosensory evoked potentials (SSEPs), allowing real-time nerve monitoring (15-18). This shift has significantly reduced the risks of neuropraxia, especially at high-risk levels such as L4/5.
Prone LLIF and the future of lumbar fusion
Performing LLIF in the prone position has led to further increases in its adoption (7,19). Prone positioning offers advantages such as posterior migration of neural structures, natural lordosis, and allows access to both anterior and posterior columns without repositioning. This enhances surgical efficiency and ergonomics. Prone LLIF is especially beneficial for spondylolisthesis and adjacent segment disease. Surgeons can first secure posterior instrumentation to reduce slips before safely placing lateral cages. Morphological changes in the psoas following slip reduction further enhance surgical safety. For revision and extension fusions, prone LLIF enables simultaneous posterior hardware release and lateral access (7). Evidence supports that lateral cages supplemented with integrated long screws can achieve robust fusion without disturbing prior posterior constructs (20). Furthermore, the prone lateral approach provides an effective method to revise failed posterior fusions, including removal of non-union cages (12,21).
Conclusions
LLIF, especially in the prone position, is reshaping the landscape of lumbar fusion surgery. It provides superior anterior access, a larger implant footprint, and improved lordosis, all within a single-position workflow. Enhanced neuromonitoring and growing surgical expertise have reduced neurological risks, supporting wider adoption. While TLIF remains the most utilised approach, the accelerating uptake and clinical advantages of LLIF indicate it is well positioned to rival TLIF as a primary interbody fusion strategy in the coming decade.
Acknowledgments
None.
Footnote
Provenance and Peer Review: This article was commissioned by the editorial office, Journal of Spine Surgery. The article did not undergo external peer review.
Funding: None.
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jss.amegroups.com/article/view/10.21037/jss-2025-01/coif). R.J.M. serves as the Editor-in-Chief of Journal of Spine Surgery. G.M.M. serves as an unpaid editorial board member of Journal of Spine Surgery. Besides, R.J.M. reports royalties from Stryker Spine, Medacta Int. and AusBio Australia, consulting fees from Elliquence USA, stocks in Medtronic Int. and Johnson & Johnson Int. G.M.M. reports consulting fees from Globus Medical, Australian Biotechnology, payments from Globus Medical, Life HealthCare and Medtronic. Y.Y.W. reports consulting fees from ATec Spine, BrainLab and Matrix Medical Innovations, payments from ATec Spine and BrainLab, and he serves as the board member of Australian Pituitary Foundation and is the shareholder of ATec Spine. The authors have no other conflicts of interest to declare.
Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Mobbs RJ, Phan K, Malham G, et al. Lumbar interbody fusion: techniques, indications and comparison of interbody fusion options including PLIF, TLIF, MI-TLIF, OLIF/ATP, LLIF and ALIF. J Spine Surg 2015;1:2-18. [PubMed]
- Medtech spinal implants market insights: United States, Clarivate. 2023. [Accessed 22 March 2025]. Available online: https://clarivate.com/life-sciences-healthcare/report/47042137-medtech-spinal-implants-market-insights-united-states/
- Malham GM, Louie PK, Brazenor GA, et al. Recombinant human bone morphogenetic protein-2 in spine surgery: recommendations for use and alternative bone substitutes-a narrative review. J Spine Surg 2022;8:477-90. [Crossref] [PubMed]
- Ikwuegbuenyi CA, Willett N, Wang E, et al. Expandable cage technology in minimally invasive transforaminal interbody fusion: where are we and what does the future hold? Expert Rev Med Devices 2025;22:349-60. [Crossref] [PubMed]
- Singh M, Balmaceno-Criss M, Daher M, et al. Restoring L4-S1 Lordosis Shape in Severe Sagittal Deformity: Impact of Correction Techniques on Alignment and Complication Profile. World Neurosurg 2024;189:e219-29. [Crossref] [PubMed]
- Huynh NV, Thomas JA, Eisen L, et al. Lateral decubitus anterior exposure of the L4-5 disc maintains safety compared with supine positioning. J Spine Surg 2024;10:333-43. [Crossref] [PubMed]
- Buckland AJ, Proctor DJ, Thomas JA, et al. Single-Position Prone Lateral Lumbar Interbody Fusion Increases Operative Efficiency and Maintains Safety in Revision Lumbar Spinal Fusion. Spine (Phila Pa 1976) 2024;49:E19-24. [Crossref] [PubMed]
- Ozgur BM, Aryan HE, Pimenta L, et al. Extreme Lateral Interbody Fusion (XLIF): a novel surgical technique for anterior lumbar interbody fusion. Spine J 2006;6:435-43. [Crossref] [PubMed]
- Huo CW, Malham GM, Biddau DT, et al. Lateral Lumbar Interbody Fusion Using Expandable vs Static Titanium Interbody Cages: A Prospective Cohort Study of Clinical and Radiographic Outcomes. Int J Spine Surg 2023;17:265-75. [Crossref] [PubMed]
- Morton MB, Wang YY, Buckland AJ, et al. Lateral lumbar interbody fusion - clinical outcomes, fusion rates and complications with recombinant human bone morphogenetic protein-2. Br J Neurosurg 2025;39:71-7. [Crossref] [PubMed]
- Malham GM, Blecher CM, Munday NR, et al. Expandable Lateral Lumbar Cages With Integrated Fixation: A Viable Option for Rostral Adjacent Segment Disease. Int J Spine Surg 2022;16:748-59. [Crossref] [PubMed]
- Phan K, Huo YR, Hogan JA, et al. Minimally invasive surgery in adult degenerative scoliosis: a systematic review and meta-analysis of decompression, anterior/lateral and posterior lumbar approaches. J Spine Surg 2016;2:89-104. [Crossref] [PubMed]
- Woods KR, Billys JB, Hynes RA. Technical description of oblique lateral interbody fusion at L1-L5 (OLIF25) and at L5-S1 (OLIF51) and evaluation of complication and fusion rates. Spine J 2017;17:545-53. [Crossref] [PubMed]
- Emami A, Patel N, Coban D, et al. Comparing clinical and radiological outcomes between single-level OLIF and XLIF: A systematic review and meta-analysis. N Am Spine Soc J 2023;14:100216. [Crossref] [PubMed]
- Tohmeh AG, Rodgers WB, Peterson MD. Dynamically evoked, discrete-threshold electromyography in the extreme lateral interbody fusion approach. J Neurosurg Spine 2011;14:31-7. [Crossref] [PubMed]
- Patel A, McDermott MR, Mundis GM Jr, et al. The "20-minute Rule" in Lateral Lumbar Interbody Fusion. Fact or Fiction? A Multi-Center Analysis of 658 Patients. Global Spine J 2025; Epub ahead of print. [Crossref] [PubMed]
- Uribe JS, Isaacs RE, Youssef JA, et al. Can triggered electromyography monitoring throughout retraction predict postoperative symptomatic neuropraxia after XLIF? Results from a prospective multicenter trial. Eur Spine J 2015;24:378-85. [Crossref] [PubMed]
- Malham GM, Hamer RP, Biddau DT, et al. Do evoked potentials matter? Pre-pathologic signal change and clinical outcomes with expandable cages in lateral lumbar interbody fusion surgery. J Clin Neurosci 2022;98:248-53. [Crossref] [PubMed]
- Rajkumar VS, Owler B, Dawes B, et al. Establishment of the prone transpsoas fusion surgery in Australia—a survey and analysis of major complications in early adopters. J Spine Surg 2025;11:15-23. [Crossref] [PubMed]
- Malham GM, Wang W, McGuckin JP, et al. Maximizing screw length in expandable lateral lumbar interbody spacers with integrated fixation may obviate the need for supplemental pedicle screws. Spine J 2025;25:1564-73. [Crossref] [PubMed]
- Farber SH, Ehresman J, Lee BS. Novel Use of Bilateral Prone Transpsoas Approach for the Treatment of Transforaminal Interbody Fusion Pseudarthrosis and Interbody Cage Subsidence. Oper Neurosurg (Hagerstown) 2024;27:86-93. [Crossref] [PubMed]

